Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 3
1990 1
1991 1
1998 1
2001 1
2002 3
2003 2
2004 1
2005 1
2008 2
2009 1
2010 3
2017 1
2018 1
2019 4
2020 6
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.
Ballester-Lopez A, Linares-Pardo I, Koehorst E, Núñez-Manchón J, Pintos-Morell G, Coll-Cantí J, Almendrote M, Lucente G, Arbex A, Magaña JJ, Murillo-Melo NM, Lucia A, Monckton DG, Cumming SA, Ramos-Fransi A, Martínez-Piñeiro A, Nogales-Gadea G. Ballester-Lopez A, et al. Among authors: cumming sa. Genes (Basel). 2020 Jul 7;11(7):757. doi: 10.3390/genes11070757. Genes (Basel). 2020. PMID: 32645888 Free PMC article.
Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1.
Ballester-Lopez A, Koehorst E, Linares-Pardo I, Núñez-Manchón J, Almendrote M, Lucente G, Arbex A, Puente C, Lucia A, Monckton DG, Cumming SA, Pintos-Morell G, Coll-Cantí J, Ramos-Fransi A, Martínez-Piñeiro A, Nogales-Gadea G. Ballester-Lopez A, et al. Among authors: cumming sa. Genes (Basel). 2020 Nov 7;11(11):1321. doi: 10.3390/genes11111321. Genes (Basel). 2020. PMID: 33171734 Free PMC article.
Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial.
Kurkiewicz A, Cooper A, McIlwaine E, Cumming SA, Adam B, Krahe R, Puymirat J, Schoser B, Timchenko L, Ashizawa T, Thornton CA, Rogers S, McClure JD, Monckton DG. Kurkiewicz A, et al. Among authors: cumming sa. PLoS One. 2020 Apr 14;15(4):e0231000. doi: 10.1371/journal.pone.0231000. eCollection 2020. PLoS One. 2020. PMID: 32287265 Free PMC article.
Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort.
Cumming SA, Jimenez-Moreno C, Okkersen K, Wenninger S, Daidj F, Hogarth F, Littleford R, Gorman G, Bassez G, Schoser B, Lochmüller H, van Engelen BGM, Monckton DG; OPTIMISTIC Consortium. Cumming SA, et al. Neurology. 2019 Sep 3;93(10):e995-e1009. doi: 10.1212/WNL.0000000000008056. Epub 2019 Aug 8. Neurology. 2019. PMID: 31395669 Free PMC article. Clinical Trial.
On-chip immunoprecipitation for protein purification.
Sandison ME, Cumming SA, Kolch W, Pitt AR. Sandison ME, et al. Among authors: cumming sa. Lab Chip. 2010 Oct 21;10(20):2805-13. doi: 10.1039/c005295g. Epub 2010 Aug 17. Lab Chip. 2010. PMID: 20714512
A DM1 patient with CCG variant repeats: Reaching the diagnosis.
Cumming SA, Oliwa A, Stevens G, Ballantyne B, Mann C, Razvi S, Longman C, Monckton DG, Farrugia ME. Cumming SA, et al. Neuromuscul Disord. 2021 Mar;31(3):232-238. doi: 10.1016/j.nmd.2020.12.005. Epub 2020 Dec 24. Neuromuscul Disord. 2021. PMID: 33546847
35 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page